An observational study in Gestational Diabetes Mellitus in Pregnancy, sponsored by Women's Hospital School Of Medicine Zhejiang University. Status unknown at 1 site in China. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-08-04.
Sponsored by Women's Hospital School Of Medicine Zhejiang University · Observational
The aim of this study is to explore the diagnostic efficacy of oral glucose tolerance test in early pregnancy and establish the prediction model for gestational diabetes mellitus, so as to provide the optimal screening of gestational diabetes mellitus in the first trimester. The treatment started when the pregnancy was confirmed by transvaginal ultrasound (around 6 weeks of gestation) and continued until 42 days postpartum. The study is a single center, prospective cohort study. A total of 781 participants within 14 weeks of gestation were recruited.
842 studies on the registry are indexed under Diabetes, Gestational; 199 are open to participants now.
This study's enrollment of 781 is above the median of 198 across 270 observational studies indexed under Diabetes, Gestational.
Browse Diabetes, Gestational studies →Women's Hospital School Of Medicine Zhejiang University is the lead sponsor of 74 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects were confirmed "intrauterine live birth" by ultrasound examination and were during 7-14 weeks of gestation confirmed by the combination of their last menstrual period and nuchal translucency ultrasound examination.
Exclusion Criteria:
The 75g oral glucose tolerance test was performed before 14 weeks of gestation, and any of the fasting, 1-hour and 2-hours blood glucose was ≥ 5.1, 10.0 and 8.5 mmol/L, respectively.
Other: hyperglycemia exposure in the first trimester
The 75g oral glucose tolerance test was performed before 14 weeks of gestation, and the fasting, 1-hour and 2-hours blood glucose were all \< 5.1, 10.0 and 8.5 mmol/L, respectively.
The exposure means the hyperglycemia identified by the 75g oral glucose tolerance test before the 14 weeks of gestation
gestational diabetes mellitus
any of the fasting, 1-hour and 2-hour blood glucose ≥ 5.1, 10.0, 8.5 mmol/L, respectively, in the 75g oral glucose tolerance test during 24-28 weeks of gestation
Time frame: 24-28 weeks of gestation
gestational weight gain
total weight gain from pre-pregnancy until delivery
Time frame: before delivery
gestational age at delivery
gestational weeks at the day of delivery
Time frame: through study completion, an average of 39 gestational weeks
birthweight
birthweight of the infant
Time frame: within 24 hours after birth
neonatal weight, height and head circumference
baby's weight, height and head circumference at 42 days after birth
Time frame: 42 days after birth
Plan to share: Undecided
This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Women's Hospital School Of Medicine Zhejiang University